We observed that the application of β-catenin-overexpressing iTS CM, Eno1, and Ubc significantly reduced the level of PD-L1 in EO771 mammary tumor cells as well as TRAMP prostate tumor cells (Figure 7E, Figure S8E). Here, ENO1 is linked to breast cancer.